Summary
Jenny Zhang will be a featured panelist on the IP Law Year-in-Review Panel at the Utah Bar Association – Intellectual Property Law Summit.
Speakers
- /en/people/z/zhang-jenny
Jenny J. Zhang
Associate
Related Content
- AlertMay 22, 2024
The Appeals Review Panel’s In Re Xencor Decision: The USPTO Provides Its Position on Written Description and Means-Plus-Function Claims
- AlertMarch 12, 2024
USPTO’s New Guidance on AI-Assisted Inventions: The Impact on the Use of AI in the Life Sciences
- AlertFebruary 13, 2024
USPTO Issues New Guidance on Patenting AI-Assisted Inventions
- InsightJanuary 16, 2024
What’s Next for AI? Six Areas to Watch in 2024
- InsightNovember 30, 2023
How To Reduce the Risk of Copyright Infringement When Using Generative AI To Write Code
- InsightOctober 31, 2023
Coding with AI in an Open-Source World
- AlertAugust 30, 2023
In re Cellect: Federal Circuit Opens New Path for Double Patenting Challenges
- AlertAugust 29, 2023
Biden Executive Order Puts Focus on Domestic Manufacturing of Inventions Created Using Federal Funding
- Speaking EngagementsJuly 24, 2024 | 2:00 PM - 3:15 PM ET
ACS Webinar - Avoiding IP Own Goals in Drug Discovery: Best Practices for Obtaining (and Keeping) Your IP
- Awards and Rankings20 June 2024
Best Lawyers in France 2025 Recognizes 16 Paris Lawyers
- Press ReleaseJune 13, 2024
Rapport Therapeutics Completes $174.4 Millon Initial Public Offering and Concurrent Private Placement
- Awards and RankingsJune 11, 2024
Managing IP Names 22 Goodwin Lawyers IP Stars 2024
- Awards and RankingsJune 6, 2024
Chambers USA 2024 Recognizes Goodwin Practices and Lawyers for Exceptional Client Service
- Press ReleaseMay 29, 2024
Akili Interactive to Be Acquired by Virtual Therapeutics
- Awards and RankingsMay 24, 2024
Neel Chatterjee and Brett Schuman Named Top IP Lawyers by Daily Journal
- Press ReleaseMay 24, 2024
Aktis Oncology and Eli Lilly Collaborate on Discovery and Development of Novel Anticancer Radiopharmaceuticals; Aktis To Receive $60 Million Upfront and up to an Additional $1.1 Billion in Potential Milestones